BioSpace News Archive

Jazz Pharmaceuticals plc announced financial results for the second quarter of 2023, raised 2023 full year financial guidance and provided business updates.

Lantern Pharma Inc. announced operational highlights and financial results for the second quarter ended June 30, 2023.

Ginkgo Bioworks Holdings, Inc., which is building the leading platform for cell programming and biosecurity, announced its results for the second quarter ended June 30, 2023.

Akumin Inc., a national partner of choice for U.S. hospitals, health systems and physician groups, with comprehensive solutions addressing outsourced radiology and oncology service-line needs, announced its financial results for the quarter ended June 30, 2023.

Immunis, Inc., a private biotechnology company pioneering cellular secretome therapies for age and disease-related immune decline, is excited to announce that its Chairman, Dr. Hans Keirstead, will be a panelist at Lifespan.io’s Ending Age-Related Diseases Summit.

Astellas Pharma Inc. and DivcoWest, a DivCore Capital Company, announced plans for Astellas to open a new state-of-the-art life sciences facility at 441 Morgan Avenue, in the Cambridge Crossing neighborhood in Cambridge, Mass.

Merus N.V., a clinical-stage oncology company developing innovative, full-length multispecific antibodies, announced the pricing of an underwritten public offering of 6,818,182 common shares, at a public offering price of $22.00 per share.

Galera Therapeutics, Inc. announced that it has received a Complete Response Letter from the U.S. Food and Drug Administration regarding the Company’s New Drug Application for avasopasem manganese for radiotherapy-induced severe oral mucositis in patients with head and neck cancer undergoing standard-of-care treatment.

Surmodics, Inc., a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, announced that management will participate in the following upcoming investor conferences: The Needham Virtual MedTech & Diagnostics 1x1 Conference, which is being held from August 14‑15, 2023.